2 Top Healthcare Stocks to Buy for the Long Haul
Even prominent companies can sometimes fall out of favor with investors if the goods or services they offer become obsolete. But that's unlikely to happen to the broader healthcare sector, which makes it a good place to look for stocks to hold on to for a long time. Even so, individual companies within the industry must continue innovating to keep up with the evolution of the healthcare market to remain successful over long periods.
Some companies have proven their ability to do that and can continue down the same path for a while. Let's consider two of them: Bristol Myers Squibb (NYSE: BMY) and Novo Nordisk (NYSE: NVO). Both are excellent buy-and-forget stocks. Here's why.
Bristol Myers is one of the largest pharmaceutical companies in the world with a portfolio of products that focuses predominantly on oncology and immunology, the two largest and fastest-growing therapeutic areas in the industry. Last year, the drugmaker had seven products that each generated more than $1 billion in revenue. And of those, six grew their sales on a year-over-year basis.
Source Fool.com
